PROSTAGLANDINE F2A/ANAFASIS 50MG/10ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
PROSTAGLANDINE F2A/ANAFASIS 50MG/10ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Prostaglandin a1
Product identification
Medicine name:
PROSTAGLANDINE F2A/ANAFASIS 50MG/10ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Prostaglandin a1
Target species:
-
Pig (sow)
-
Cattle (cow)
-
Horse (mare)
-
Sheep (ewe)
-
Dog (bitch)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Prostaglandin a150.00/milligram(s)10.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig (sow)
-
Not applicableno withdrawal period
-
-
Cattle (cow)
-
Not applicableno withdrawal period
-
-
Horse (mare)
-
Not applicableno withdrawal period
-
-
Sheep (ewe)
-
Not applicableno withdrawal period
-
-
Dog (bitch)
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG02AD
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Uplab Pharmaceutical Company Ltd.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 88486/14-12-2015/K-0210301
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet